Announcement on Voluntary Disclosure of Clinical Trial Approval for New Indications of a Product of a Holding Subsidiary

About this update from Sansure Biotech Inc. Class A

Announcement on Voluntary Disclosure of Clinical Trial Approval for New Indications of a Product of a Holding Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sansure Biotech Inc. Class A